Zeneca sues US rival over `false' drug claims
Saturday 27 February 1999
In a lawsuit filed in a New York court, the British group alleged that the US drug giant "systematically and deliberately attempted to mislead doctors" on the benefits of Evista, an osteoporosis drug.
According to Zeneca, Lilly's sales representatives told physicians that the drug helped to reduce the risk of breast cancer, even though it had only been approved as a treatment for osteoporosis - a bone-thinning disease which affects middle-aged women.
The UK company is the maker of Nolvadex, the leading product for the treatment of breast cancer, and one of Zeneca's best selling drugs. Last year Nolvadex sales totalled $369m in the US and around $500m worldwide. The drug is used by around 400,000 US patients and last year received approval to be used to prevent the disease in high-risk women.
The lawsuit said that Lilly's false claims prompted a number of doctors to prescribe Evista for breast cancer, leading to a drop in the sales of Nolvadex.
According to a Zeneca survey of over 500 doctors, one in three physicians were led to believe that Evista could be used as an alternative to Nolvadex. .Zeneca, which is merging with its Swedish rival Astra, claimed that Lilly's campaign created "serious risk to public health" as more and more women are using Evista instead of Nolvadex. The British company is seeking undisclosed damages and wants Lilly to pay for an advertising campaign to deny the Evista cancer claims.
A spokesman for Lilly yesterday denied Zeneca's allegations: "We don't feel there is anything inappropriate in our promotion."
- 1 The BBC has just done more to eradicate ‘terrorism’ than all our wars since 9/11
- 2 Dog thinks owner is drowning in lake, dives in and tries to pull him out
- 3 Saudi preacher who 'raped and tortured' his five -year-old daughter to death is released after paying 'blood money'
- 4 Chilling drone footage captures Auschwitz ahead of 70th anniversary of liberation
- 5 Narendra Modi: Indian Prime Minister wears suit with pinstripes that spell his name to meet Barack Obama
Auschwitz liberation 70th anniversary: Woman sent to three Nazi death camps describes surviving gas chamber
Saudi preacher who 'raped and tortured' his five -year-old daughter to death is released after paying 'blood money'
Greece elections: Greek PM Alexis Tsipras takes aim at 'neo-liberal' Europe as country gears up for prolonged austerity battle
Pornhub star Mia Khalifa receives death threats after being ranked the site's top adult actress
Prince Philip set to be knighted by Australia: Celebrate by reading his greatest gaffes
'We would evict Queen from Buckingham Palace and allocate her council house,' say Greens
French court convicts three over homophobic tweets, in case hailed as a 'significant victory' by LGBT rights campaigners
Greece elections: Syriza and EU on collision course after election win for left-wing party
British Muslim school children suffering a backlash of abuse following Paris attacks
Islamic history is full of free thinkers - but recent attempts to suppress critical thought are verging on the absurd
30,000 reasons why the rhetoric on immigrants claiming benefits can stop now
iJobs Money & Business
£30000 - £32000 per annum + benefits : Ashdown Group: A highly successful, int...
£18000 - £20000 per annum: Recruitment Genius: This rapidly expanding business...
£25 - 28k + Bonus: Guru Careers: An In-house / Internal Recruiter is needed to...
Negotiable: Recruitment Genius: A Tax Assistant is required to join a leading ...